Abstract
Purpose
The study was undertaken with the aim to determine gender-specific differences in incident hemodialysis (HD) patient and their changes over time.
Methods
The retrospective longitudinal closed cohort study involved 441 incident patients starting HD in 2014 and followed for 1–59 (median 43, IQR 40) months. Demographic, clinical data, treatment characteristics, laboratory findings and outcome were abstracted from the patients’ medical records.
Results
The relative number of males on HD was about twice that of females throughout the five years investigated. At the beginning of the study, no significant differences were found in the main demographic and clinical characteristics except that diabetes was more often the underlying disease in men than in women. Systolic blood pressure decreased over time significantly more in females than in males. Throughout the study spKt/V was significantly higher in females than in males, but it increased in patients of both genders. There were no gender differences for comorbidities, vascular access and the majority of laboratory findings except for higher serum levels of creatinine and CRP in men than in women. Relatively more females were treated with erythropoiesis stimulating agents and phosphate binders than males. Age and malignancy were selected as significant predictors of mortality for both genders, and, in addition, polycystic kidney disease, serum level of albumin and CRP for men, but spKt/V for women.
Conclusion
Some significant gender differences were observed throughout, while others appeared during the study but none of them were due to gender inequalities in the applied treatment.
Similar content being viewed by others
References
Hecking M, Bieber BA, Ethier J et al (2014) Sex-specific differences in hemodialysis prevalence and practices and the male-to-female mortality rate: the Dialysis Outcomes and Practice Patterns Study (DOPPS). PLoS Med 11:e1001750. https://doi.org/10.1371/journal.pmed.1001750
Carrero JJ, Hecking M, Chesnaye NC, Jager KJ (2018) Sex and gender disparities in the epidemiology and outcomes of chronic kidney disease. Nat Rev Nephrol 14:151–164. https://doi.org/10.1038/nrneph.2017.181
Antlanger M, Noordzij M, van de Luijtgaarden M, On behalf of the ERA-EDTA Registry et al (2019) Sex differences in kidney replacement therapy initiation and maintenance. Clin J Am Soc Nephrol 14:1616–1625. https://doi.org/10.2215/CJN.04400419
Murphy D, McCulloch CE, Lin F, Centers for Disease Control and Prevention Chronic Kidney Disease SurveillanceTeam et al (2016) Trends in prevalence of chronic kidney disease in the United States. Ann Intern Med 165:473–481. https://doi.org/10.7326/m16-0273
Djukanović L, Aksić-Miličević B, Antić M et al (2012) Epidemiology of end-stage renal disease and hemodialysis treatment in Serbia at the turn of the millennium. Hemodial Int 16:517–525. https://doi.org/10.1111/j.1542-4758.2012.00681.x
ERA-EDTA Registry: ERA-EDTA Registry Annual Report 2018. Amsterdam: Amsterdam UMC, location AMC, Department of Medical Informatics; 2020 https://www.era-online.org/registry/AnnRep2018.pdf [Accessed 13 August 2021].
Gómez-Marcos MÁ, Recio-Rodríguez JI, Gómez-Sánchez L, LOD-DIABETES Group et al (2015) Gender differences in the progression of target organ damage in patients with increased insulin resistance. Cardiovasc Diabetol 14:132. https://doi.org/10.1186/s12933-015-0293-1
Yu MK, Katon W, Young BA (2015) Associations between sex and incident chronic kidney disease in a prospective diabetic cohort. Nephrology 20:451–458. https://doi.org/10.1111/nep.12468
Ortona E, Pierdominici M, Maselli A, Veroni C, Aloisi F, Shoenfeld Y (2016) Sex-based differences in autoimmune diseases. Ann Ist Super Sanita 52:205–212. https://doi.org/10.4415/ANN_16_02_12
Neugarten J, Golestaneh L (2019) Influence of sex on the progression of chronic kidney disease. Mayo Clin Proc 94:1339–1356. https://doi.org/10.1016/j.mayocp.2018.12.024
Ricardo AC, Yang W, Sha D, Appel LJ, Chen J, KrouselWood M, CRIC Investigators et al (2019) Sex- related disparities in CKD progression. J Am Soc Nephrol 30:137–146. https://doi.org/10.1681/ASN.2018030296
Weigert A, Drozdz M, Silva F et al (2019) Influence of gender and age on haemodialysis practices: a European multicentre analysis. Clin Kidney J 13:217–224. https://doi.org/10.1093/ckj/sfz069
Oliveira TS, Valente AT, Caetano CG, Garagarza CA (2017) Nutritional parameters as mortality predictors in haemodialysis: differences between genders. J Ren Care 43:83–91. https://doi.org/10.1111/jorc.12201
Kainz A, Berner C, Ristl R et al (2019) Sex-specific analysis of haemodialysis prevalence, practices and mortality over time: the Austrian dialysis registry from 1965 to 2014. Nephrol Dial Transplant 34:1026–1035. https://doi.org/10.1093/ndt/gfy322
Daugirdas JT (1993) Second generation logarithmic estimates of single-pool variable volume Kt/V: an analysis of error. J Am Soc Nephrol 4:1205–1213. https://doi.org/10.1681/ASN.V451205
Iseki K, Nakai S, Shinzato T, Nagura Z, Akiba T, Patient Registration Committee of the Japanese Society for Dialysis Therapy (2005) Increasing gender difference in the incidence of chronic dialysis therapy in Japan. Ther Apher Dial 9:407–411. https://doi.org/10.1111/j.1744-9987.2005.00318.x
Johansen KL, Chertow GM, Foley RN et al (2021) US Renal Data System 2020 Annual data report: epidemiology of kidney disease in the United States. Am J Kidney Dis 77(1):Svii-Sviii. https://doi.org/10.1053/j.ajkd.2021.01.002 (S1-S597)
Fernandez-Prado R, Fernandez-Fernandez B, Ortiz A (2018) Women and renal replacement therapy in Europe: lower incidence, equal access to transplantation, longer survival than men. Clin Kidney J 11:1–6. https://doi.org/10.1093/ckj/sfx154
Cobo G, Hecking M, Port FK, Exner I, Lindholm B, Stenvinkel P, Carrero JJ (2016) Sex and gender differences in chronic kidney disease: progression to end-stage renal disease and haemodialysis. Clin Sci 130:1147–1163. https://doi.org/10.1042/CS20160047
McKercher C, Jose MD, Grace B, Clayton PA, Walter M (2017) Gender differences in the dialysis treatment of Indigenous and non-Indigenous Australians. Aust N Z J Public Health 41:15–20. https://doi.org/10.1111/1753-6405.12621
Shah S, Leonard AC, Meganathan K, Christianson AL, Thakar CV (2018) Gender and racial disparities in initial hemodialysis access and outcomes in incident end-stage renal disease patients. Am J Nephrol 48:4–14. https://doi.org/10.1159/000490624
Park JM, Lee JH, Jang HM, Park Y, Kim YS, Kang SW, Clinical Research Center for End Stage Renal Disease (CRC for ESRD) Investigators et al (2018) Survival in patients on hemodialysis: effect of gender according to body mass index and creatinine. PLoS ONE 13:e0196550. https://doi.org/10.1371/journal.pone.0196550
National Kidney Foundation (2015) KDOQI clinical practice guideline for hemodialysis adequacy: 2015 update. Am J Kidney Dis 66:884–930. https://doi.org/10.1053/j.ajkd.2015.07.015
Spalding EM, Chandna SM, Davenport A, Farrington K (2008) Kt/V underestimates the hemodialysis dose in women and small men. Kidney Int 74:348–355. https://doi.org/10.1038/ki.2008.185
Daugirdas JT, Depner TA, Greene T, Kuhlmann MK, Levin NW, Chertow GM, Rocco MV (2008) Surface-area-normalized Kt/V: a method of rescaling dialysis dose to body surface area-implications for different-size patients by gender. Semin Dial 21:415–421. https://doi.org/10.1111/j.1525-139X.2008.00482.x
Depner T, Daugirdas J, Greene T, Allon M, Beck G, Chumlea C et al (2004) Dialysis dose and the effect of gender and body size on outcome in the HEMO Study. Kidney Int 65:1386–1394. https://doi.org/10.1111/j.1523-1755.2004.00519.x
Ramirez SP, Kapke A, Port FK et al (2012) Dialysis dose scaled to body surface area and size-adjusted, sex-specific patient mortality. Clin J Am Soc Nephrol 7:1977–1987. https://doi.org/10.2215/CJN.00390112
Naveh-Many T, Epstein E, Silver J (1995) Oestrogens and calcium regulatory hormones: potential implications for bone. Curr Opin Nephrol Hypertens 4:319–323. https://doi.org/10.1097/00041552-199507000-00006
Prince RL (1994) Estrogen effects on calciotrophic hormones and calcium homeostasis. Endocr Rev 15:301–309. https://doi.org/10.1210/edrv-15-3-301
Van Abel M, Hoenderop JG, Dardenne O, St Arnaud R, Van Os CH, Van Leeuwen HJ, Bindels RJM (2002) 1,25-dihydroxyvitamin D(3)-independent stimulatory effect of estrogen on the expression of ECaC1 in the kidney. J Am Soc Nephrol 13:2102–2109. https://doi.org/10.1097/01.asn.0000022423.34922.2a
Lomonte C, Cazzato F, Casucci F, Chimienti D, Bruno A, Cocola S, Verrelli EA, Basile C (2005) Female hemodialysis patients have an increased risk of nodular hyperplasia of parathyroid glands. J Nephrol 18:92–95
Umeukeje EM, Merighi JR, Browne T, Wild M, Alsmaan H, Umanath K et al (2016) Health care providers’ support of patients’ autonomy, phosphate medication adherence, race and gender in end stage renal disease. J Behav Med 39:1104–1114. https://doi.org/10.1007/s10865-016-9745-7
Lopez-Gomez JM, Portoles JM, Aljama P (2008) Factors that condition the response to erythropoietin in patients on hemodialysis and their relation to mortality. Kidney Int Suppl 111:S75-81. https://doi.org/10.1038/ki.2008.523
Kainz A, Mayer B, Kramar R, Oberbauer R (2010) Association of ESA hypo-responsiveness and haemoglobin variability with mortality in haemodialysis patients. Nephrol Dial Transplant 25:3701–3706. https://doi.org/10.1093/ndt/gfq287
Fernandez-Prado R, Castillo-Rodriguez E, Velez-Arribas FJ, Gracia-Iguacel C, Ortiz A (2016) Women and renal replacement therapy in Europe: lower incidence, equal access to transplantation, longer survival than men. Am J Med 129:1259–1263. https://doi.org/10.1093/ckj/sfx154
Funding
This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflicts of interest.
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Djukanović, L., Ležaić, V., Dimković, N. et al. Gender-specific differences in hemodialysis patients: a multicenter longitudinal study from Serbia. Int Urol Nephrol 54, 3233–3242 (2022). https://doi.org/10.1007/s11255-022-03247-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11255-022-03247-9